相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ohtahara syndrome with emphasis on recent genetic discovery
Piero Pavone et al.
BRAIN & DEVELOPMENT (2012)
Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2: A Retrospective Review of 31 Patients
Scott R. Plotkin et al.
OTOLOGY & NEUROTOLOGY (2012)
Empirical development of improved diagnostic criteria for neurofibromatosis 2
Michael E. Baser et al.
GENETICS IN MEDICINE (2011)
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
Victor-Felix Mautner et al.
NEURO-ONCOLOGY (2010)
Neurofibromatosis type 1 and infantile spasms
Martino Ruggieri et al.
CHILDS NERVOUS SYSTEM (2009)
Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
Scott R. Plotkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2
Martina M. Bosch et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: A study of 24 patients
M Ruggieri et al.
NEUROPEDIATRICS (2005)
Neurofibromatosis 2 in the pediatric population
F Nunes et al.
JOURNAL OF CHILD NEUROLOGY (2003)
The clinical and diagnostic implications of mosaicism in the neurofibromatoses
M Ruggieri et al.
NEUROLOGY (2001)
分享论文
